Uppsala Reports has been around for many years – sharing stories from the WHO PIDM and offering content on the latest developments in medicines safety around the world and at UMC. In our latest issue you can read more about vaccine safety communication and vaccine hesitancy, deprescribing practices in the UK, and COVID-19 vaccine safety monitoring. ✅ http://ow.ly/8W2C50Ha9gl Subscribe and never miss a new issue 👉http://ow.ly/SsYG50HGrUP #pharmacovigilance #UppsalaReports | Uppsala Monitoring Ce
0:53
Uppsala Reports has been around for many years – sharing stories from the WHO PIDM and offering content on the latest developments in medicines safety around the world and at UMC. In our latest issue you can read more about vaccine safety communication and vaccine hesitancy, deprescribing practices in the UK, and COVID-19 vaccine safety monitoring. ✅ http://ow.ly/8W2C50Ha9gl Subscribe and never miss a new issue 👉http://ow.ly/SsYG50HGrUP #pharmacovigilance #UppsalaReports | Uppsala Monitoring Ce
135 viewsFeb 22, 2022
FacebookUppsala Monitoring Centre
The latest issue of our magazine, Uppsala Reports, is available for download. Included in this issue are articles exploring the spread of misinformation and the complexities of causality in drug safety monitoring. As usual, we also share the latest news and updates from UMC and around the world of pharmacovigilance. To get up to date on these and other related topics, download your copy of Uppsala Reports 👉 http://ow.ly/cfoH50EyGnK | Uppsala Monitoring Centre
0:17
The latest issue of our magazine, Uppsala Reports, is available for download. Included in this issue are articles exploring the spread of misinformation and the complexities of causality in drug safety monitoring. As usual, we also share the latest news and updates from UMC and around the world of pharmacovigilance. To get up to date on these and other related topics, download your copy of Uppsala Reports 👉 http://ow.ly/cfoH50EyGnK | Uppsala Monitoring Centre
104 viewsMay 6, 2021
FacebookUppsala Monitoring Centre
Dr Rachida Bencheikh, Director of Centre Anti Poison et de Pharmacovigilance in Morocco (CAPM), realises that more robust strategies are required in the struggle against the threat of harmful medications. That’s why she has turned to the radio airwaves to spread knowledge on safer use of medicines and build trust among the public. | Uppsala Monitoring Centre
5:41
Dr Rachida Bencheikh, Director of Centre Anti Poison et de Pharmacovigilance in Morocco (CAPM), realises that more robust strategies are required in the struggle against the threat of harmful medications. That’s why she has turned to the radio airwaves to spread knowledge on safer use of medicines and build trust among the public. | Uppsala Monitoring Centre
48.5K viewsJul 18, 2018
FacebookUppsala Monitoring Centre
Dr Darko Krnić, Head of the Pharmacovigilance Department at Agency for Medicinal Products and Medical Devices in Croatia (HALMED) says that he is proud of his team and that they, like other professionals he has met around the world, are all working for the same goal: safer healthcare for everyone. In an age of “fake news” Dr Krnić stresses the threat to children’s health posed by misinformation about vaccines. | Uppsala Monitoring Centre
6:15
Dr Darko Krnić, Head of the Pharmacovigilance Department at Agency for Medicinal Products and Medical Devices in Croatia (HALMED) says that he is proud of his team and that they, like other professionals he has met around the world, are all working for the same goal: safer healthcare for everyone. In an age of “fake news” Dr Krnić stresses the threat to children’s health posed by misinformation about vaccines. | Uppsala Monitoring Centre
21K viewsJul 25, 2018
FacebookUppsala Monitoring Centre
We spoke to Noraisyah Mohd Sani, Head of Pharmacovigilance Section, National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia. She describes the challenges that Malaysia faces in regards to pharmacovigilance, patients reporting adverse drug reactions and what strategies are in place to detect signals and encourage reporting. Watch the full interview on YouTube: https://youtu.be/iqPrrR2fpuA | Uppsala Monitoring Centre
1:06
We spoke to Noraisyah Mohd Sani, Head of Pharmacovigilance Section, National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia. She describes the challenges that Malaysia faces in regards to pharmacovigilance, patients reporting adverse drug reactions and what strategies are in place to detect signals and encourage reporting. Watch the full interview on YouTube: https://youtu.be/iqPrrR2fpuA | Uppsala Monitoring Centre
4K viewsJan 13, 2017
FacebookUppsala Monitoring Centre
𝙒𝙝𝙖𝙩 𝙙𝙤𝙚𝙨 #𝙈𝙚𝙙𝙎𝙖𝙛𝙚𝙩𝙮𝙒𝙚𝙚𝙠 𝙢𝙚𝙖𝙣 𝙩𝙤 𝙮𝙤𝙪? This year marks 10 years of the international campaign to raise awareness of pharmacovigilance and encourage reporting of adverse drug reactions. To celebrate, we asked our pharmacovigilance and patient safety stakeholders what #MedSafetyWeek means to them. Manal Younus, Ban Al-Shimran, Tamara Emad, Rand Idris Thanoon, and Fadhaa Mohammed Mehdi share Iraq🇮🇶's Med Safety Story in the film below👇 📆 Join us from 𝟯–𝟵 𝗡𝗼𝘃𝗲�
1:30
𝙒𝙝𝙖𝙩 𝙙𝙤𝙚𝙨 #𝙈𝙚𝙙𝙎𝙖𝙛𝙚𝙩𝙮𝙒𝙚𝙚𝙠 𝙢𝙚𝙖𝙣 𝙩𝙤 𝙮𝙤𝙪? This year marks 10 years of the international campaign to raise awareness of pharmacovigilance and encourage reporting of adverse drug reactions. To celebrate, we asked our pharmacovigilance and patient safety stakeholders what #MedSafetyWeek means to them. Manal Younus, Ban Al-Shimran, Tamara Emad, Rand Idris Thanoon, and Fadhaa Mohammed Mehdi share Iraq🇮🇶's Med Safety Story in the film below👇 📆 Join us from 𝟯–𝟵 𝗡𝗼𝘃𝗲�
2.9K views10 months ago
FacebookUppsala Monitoring Centre
🎥 Signals of adverse drug reactions (ADR) can be based on different study designs, including clinical trials, observational studies, meta-analyses, and case reports. Daniele Sartori sat down in the Research Corner to shine a light on the evidence base and features of ADR reports. Watch the film below👇 Curious about the topic? Access the report for further reading 👉 doi.org/10.1007/s40264-022-01258-0 #pharmacovigilance #PatientSafety | Uppsala Monitoring Centre
2:57
🎥 Signals of adverse drug reactions (ADR) can be based on different study designs, including clinical trials, observational studies, meta-analyses, and case reports. Daniele Sartori sat down in the Research Corner to shine a light on the evidence base and features of ADR reports. Watch the film below👇 Curious about the topic? Access the report for further reading 👉 doi.org/10.1007/s40264-022-01258-0 #pharmacovigilance #PatientSafety | Uppsala Monitoring Centre
132 views10 months ago
FacebookUppsala Monitoring Centre
0:18
🐾 While there may be crossovers between #veterinary and human #pharmacovigilance, there are also unique challenges to the animal practice. What should we consider when reporting breed-specific adverse drug reactions, coding ADR reports, or managing initiatives like the EU🇪🇺 Veterinary #BigData Strategy? James Mount of Läkemedelsverket tells us more in part II of our veterinary PV episode of #DrugSafetyMatters. 🎧 Listen today 👉 ow.ly/9GlB50UVHqC | Uppsala Monitoring Centre
99 viewsFeb 12, 2025
FacebookUppsala Monitoring Centre
1:03
The first week of the 19th International Pharmacovigilance Training Course is almost over. Here is a short video with some highlights of the training sessions and talks that have taken place. Thanks to everyone who has been involved. | Uppsala Monitoring Centre
1.7K viewsMay 11, 2017
FacebookUppsala Monitoring Centre
2:37
A group of researchers from UMC recently set out to evaluate adverse drug reactions from COVID-19 treatments, with a particular view to sex differences. At ISPE's Special COVID-19 Session on 30 November, UMC's pharmacovigilance scientist Alem Zekarias will review the team's findings. Don't miss it! Free registration here: http://ow.ly/BN5D50CrWQm | Uppsala Monitoring Centre
530 viewsNov 23, 2020
FacebookUppsala Monitoring Centre
1:04
🎥 Quality standardised data is key to ensuring the safety of medicines and vaccines. As part of our support to the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM), UMC offers tools for the foundation of a #pharmacovigilance system, including collecting, managing, and sharing safety data on medicines and vaccines. Mary Joice Reguera tells us how VigiFlow has helped the Food and Drug Administration of the Philippines🇵🇭 to collect data, manage ADRs and AEFIs, a
258 viewsSep 6, 2024
FacebookUppsala Monitoring Centre
6:42
Collecting and analysing national and global vaccine safety surveillance data is pertinent to identify emerging safety issues and a key component of #pharmacovigilance. As #WorldImmunizationWeek ends for 2024, we're putting a spotlight on how UMC and the World Health Organization (WHO) work together to develop and improve new and existing tools to assist members of the WHO Programme for International Drug Monitoring (PIDM) in their monitoring of adverse events following immunisation (AEFIs). Dis
76 viewsApr 30, 2024
FacebookUppsala Monitoring Centre
5:01
🌍 🤝 The safety of patients worldwide requires a global network dedicated to monitoring the potential risks of medicines and vaccines. Since 1968, the World Health Organization (WHO) Programme for International Monitoring (PIDM) has brought members together to collaborate nationally and internationally to reinforce regulatory systems and place patients at the heart of pharmacovigilance and global #healthcare. Our role in education and training, developing PV tools, and as the custodian of VigiB
131 viewsMar 6, 2024
FacebookUppsala Monitoring Centre
1:37
🎥 Medication errors are a leading cause of avoidable harm in healthcare, affecting millions of people worldwide each year. These mistakes hurt patients and put a significant financial strain on healthcare systems. By understanding the different types of errors and finding effective ways to prevent them, we can improve the safety of medicines for everyone ✅ Learn more about the critical stages where medication errors occur in the film below👇 and read #UppsalaReports for the full picture 👉 ow.l
241 views6 months ago
FacebookUppsala Monitoring Centre
6:02
🎥 As part of our support to the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM), UMC offers tools for the foundation of a #pharmacovigilance system, including collecting, managing, and sharing safety data. Since 2019, Invima - Instituto Nacional de Vigilancia de Medicamentos y Alimentos has used VigiFlow as its national safety surveillance database to monitor the safety of medicines and vaccines in Colombia🇨🇴. With #VigiFlow and connected applications, healt
161 views8 months ago
FacebookUppsala Monitoring Centre
0:16
Have you heard? Our #pharmacovigilance communications resource the PV Cycle is now available en français. Follow the visual narrative to learn how each stage of the medicines safety cycle works and the importance of reporting side effects. 👀 Découvrez l’histoire de Lisa 👉 ow.ly/PGKr50NiCQg | Uppsala Monitoring Centre
114 viewsMar 20, 2023
FacebookUppsala Monitoring Centre
3:08
🎥 All medicines and vaccines come with benefits and risks. While the practice of #pharmacovigilance and signal detection has evolved since the formation of the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM) in 1968, the principles remain the same: to identify signals of potential harm to patients and place #PatientSafety at the heart of pharmacovigilance. But what exactly is a signal? Learn more about the signal detection process at UMC, including screening #
49 viewsFeb 25, 2025
FacebookUppsala Monitoring Centre
1:09
🎥 𝙒𝙝𝙖𝙩 𝙙𝙤𝙚𝙨 #𝙈𝙚𝙙𝙎𝙖𝙛𝙚𝙩𝙮𝙒𝙚𝙚𝙠 𝙢𝙚𝙖𝙣 𝙩𝙤 𝙮𝙤𝙪? Since 2016, we've teamed up with pharmacovigilance and patient safety stakeholders worldwide for #MedSafetyWeek – a global campaign to raise awareness and encourage reporting of side effects. To celebrate the 10th anniversary of the campaign, we asked our partners what it means to them. Armida Zuñiga Estrada, Head of COFEPRIS shares Mexico🇲🇽's Med Safety Story in the film below👇 📆 Join us from 𝟯–𝟵 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟬�
6.1K views9 months ago
FacebookUppsala Monitoring Centre
1:00
🎥 Since 2016, we've teamed up with #pharmacovigilance and patient safety stakeholders worldwide for #MedSafetyWeek – a campaign to raise awareness and encourage reporting of side effects. These stakeholders join forces to spread campaign messaging far and wide via social media and in-person activities. As we mark 10 years of the campaign, we wanted to know: 𝙬𝙝𝙖𝙩 𝙙𝙤𝙚𝙨 #𝙈𝙚𝙙𝙎𝙖𝙛𝙚𝙩𝙮𝙒𝙚𝙚𝙠 𝙢𝙚𝙖𝙣 𝙩𝙤 𝙩𝙝𝙚𝙢? Chelsea Möller, Eunice Heitha, and Frieda Shigwedha of the Namibian M
211 views11 months ago
FacebookUppsala Monitoring Centre
0:21
It's been a long time in the making, but it's finally here. Drug Safety Matters, UMC's new podcast on pharmacovigilance, is ready to launch! Tune in next week to learn about the global business of falsified medicines with former police officer Aline Plançon. Watch this space! 🎙️ | Uppsala Monitoring Centre
544 viewsJan 22, 2020
FacebookUppsala Monitoring Centre
Why Pharmacovigilance Is More Critical Than Ever
Apr 8, 2025
news-medical.net
Unit 2 ll Pharmacovigilance 8th sem important question solution ll Pharma lectures ll
17.3K viewsMay 15, 2023
YouTubePharma lecture
History and development of Pharmacovigilance - Pharmacy Infoline
May 24, 2022
pharmacyinfoline.com
2:21
Understanding Pharmacovigilance
69.2K viewsFeb 20, 2018
YouTubeAlliance for Patient Access
1:44:56
Pharmacovigilance Training for Beginners
105.6K viewsJul 25, 2021
YouTubeGreat Online Training
1:38
What is Pharmacovigilance?
23.6K viewsAug 6, 2021
YouTubeBayer Global
2:15
How does Pharmacovigilance work?
102.6K viewsMay 22, 2018
YouTubeBayer Pharmaceuticals
31:41
Causality assessment Method | Naranjo Scale | Causality Grading | Algorithm | Pharmacovigilance NOTE
30.6K viewsJul 22, 2021
YouTubeTutor Box
58:37
Benefit risk assessment in pharmacovigilance
21.3K viewsNov 7, 2017
YouTubeUppsala Monitoring Centre
6:33
Pharmacovigilance Basics – Animated approach to learning Drug Safety
55.4K viewsSep 1, 2017
YouTubeSumit Verma
See more